Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
15 p, 1.0 MB Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength : state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) / Díez Pérez, Adolfo (Universitat Autònoma de Barcelona. Departament de Medicina) ; Brandi, Maria Luisa (University of Florence. Department of Biological, Experimental and Clinical Science) ; Al-Daghri, Nasser (King Saud University. Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science) ; Branco, Jaime C. (Universidade Nova de Lisboa. NOVA Medical School) ; Bruyère, Olivier (Université de Liège) ; Cavalli, Loredana (University of Florence. Department of Biological, Experimental and Clinical Science) ; Cooper, Cyrus (University of Southampton. MRC Lifecourse Epidemiology Unit, Southampton General Hospital) ; Cortet, Bernard (University Hospital of Lille (França)) ; Dawson-Hughes, Bess (Tufts University. Bone Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging) ; Dimai, Hans Peter (Medical University of Graz. Department of Internal Medicine, Division of Endocrinology and Diabetology) ; Gonnelli, Stefano (University of Siena. Department of Medicine, Surgery and Neurosciences) ; Hadji, Peyman (Frankfurter Hormon und Osteoporose Zentrum, Frankfurt, Germany) ; Halbout, Philippe (International Osteoporosis Foundation, Nyon, Switzerland) ; Kaufman, Jean-Marc (Universitair Ziekenhuis Gent) ; Kurth, Andreas (Mayor Teaching Hospital, Charite Medical School) ; Locquet, Medea (University of Liège. Department of Public Health, Epidemiology and Health Economics) ; Maggi, Stefania (Institute of Neuroscience. National Research Council, Aging Program) ; Matijevic, Radmila (Clinical Center of Vojvodina, Clinic for Orthopedic Surgery) ; Reginster, Jean-Yves (Université de Liège) ; Rizzoli, René (Geneva University Hospitals (Suïssa)) ; Thierry, Thomas (University of Lyon. INSERM 1059)
The purpose of this paper was to review the available approaches for bone strength assessment, osteoporosis diagnosis and fracture risk prediction, and to provide insights into radiofrequency echographic multi spectrometry (REMS), a non-ionizing axial skeleton technique. [...]
2019 - 10.1007/s40520-019-01294-4
Aging Clinical and Experimental Research, Vol. 31 (august 2019) , p. 1375-1389  
12 p, 675.8 KB Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer : Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG / Hadji, Peyman (Krankenhaus Nordwest) ; Aapro, Matti S. (Genolier Cancer Center, Switzerland) ; Body, Jean-Jacques (CHU Brugmann, Université Libre de Bruxelles, Belgium) ; Gnant, Michael (Medical University of Vienna, Austria) ; Brandi, Maria Luisa (University of Florence, Italy) ; Reginster, Jean Yves (University of Liège, Belgium) ; Zillikens, M. Carola (Erasmus MC, Rotterdam, Netherlands) ; Glüer, Claus-C. (Univeristy of Kiel, Germany) ; de Villiers, Tobie (University of Stellenbosch, Cape Town, South Africa) ; Baber, Rod (University of Sydney, Australia) ; Roodman, G. David (Indiana University School of Medicine, USA) ; Cooper, Cyrus (University of Southampton, UK) ; Langdahl, Bente (Aarhus University, Denmark) ; Palacios, Santiago (Instituto Palacios Madrid, Spain) ; Kanis, John (Catholic University of Australia, Melbourne, Australia and University of Sheffield, UK) ; Al-Daghri, Nasser (University of Riyadh, Saudi Arabia) ; Nogués Solán, Xavier (Universitat Autònoma de Barcelona) ; Eriksen, Erik Fink (University of Oslo, Norway) ; Kurth, Andreas (Klinikum Birkenwerder, Germany) ; Rizzoli, Rene (Geneva University, Switzerland) ; Coleman, Robert E. (University of Sheffield, UK)
Several guidelines have been reported for bone-directed treatment in women with early breast cancer (EBC) for averting fractures, particularly during aromatase inhibitor (AI) therapy. Recently, a number of studies on additional fracture related risk factors, new treatment options as well as real world studies demonstrating a much higher fracture rate than suggested by randomized clinical controlled trials (RCTs). [...]
2017 - 10.1016/j.jbo.2017.03.001
Journal of Bone Oncology, Vol. 7 (June 2017) , p. 1-12  
11 p, 634.6 KB Diacerein : Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO / Pavelka, Karel (Charles University) ; Bruyère, Olivier (Liège, Belgium) ; Cooper, Cyrus (Southampton, UK) ; Kanis, John A. (Sheffield, UK) ; Leeb, Burkhard F. (State Hospital Stockerau) ; Maheu, Emmanuel (St-Antoine Hospital) ; Martel-Pelletier, Johanne ; Monfort, Jordi (Hospital del Mar (Barcelona, Catalunya)) ; Pelletier, Jean-Pierre (University of Montreal Hospital Research Centre (CRCHUM)) ; Rizzoli, René (Geneva University Hospitals (Suïssa)) ; Reginster, Jean-Yves (Université de Liège) ; Universitat Autònoma de Barcelona. Departament de Medicina
Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) with anti-inflammatory, anti-catabolic and pro-anabolic properties on cartilage and synovial membrane. It has also recently been shown to have protective effects against subchondral bone remodelling. [...]
2016 - 10.1007/s40266-016-0347-4
Drugs & Aging, Vol. 33 (february 2016) , p. 75-85  

See also: similar author names
1 Reginster, J-Y
1 Reginster, J. -Y.
1 Reginster, J. Y.
5 Reginster, J.Y.
3 Reginster, Jean-Yves
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.